Literature DB >> 19851964

[Should cystic echinococcosis be investigated in patients having high eosinophil counts?].

Senem Yaman Karadam1, Hatice Ertabaklar, Cavide Sari, Yelda Dayanir, Sema Ertuğ.   

Abstract

Cystic echinococcosis (CE) caused by the metacestode form of Echinococcus granulosus is one of the important health problems in Turkey and in the world. In this study, whether or not the presence of CE in patients with a high eosinophil count should be determined was investigated. A total of 946 specimens from patients with a high eosinophil count (>or=350/mm3) were evaluated. The age of patients ranged from 1-94 years. Of the patients, 392 (41.4%) were male and 554 (58.6%), female. The specific antibody response in the specimens was determined by ELISA and IHA. Specific antibody response was detected in five sera of 946 (0.53%) patients with ELISA and IHA. The patients, with an antibody response, were evaluated further with liver ultrasonography and chest X-ray. One patient, in which an antibody response was detected, had a history of renal cell carcinoma surgery. In one patient (0.11%), CE was detected in the liver and the diagnosis was confirmed by surgery. No CE was found in the other three patients. In conclusion, eosinophilia is not a sufficient indicator for CE alone and this parasite should be sought in patients with clinical and radiological signs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19851964

Source DB:  PubMed          Journal:  Turkiye Parazitol Derg        ISSN: 1300-6320


  2 in total

1.  Surgically managed human cystic echinococcosis in north-eastern Iran: a single center's experience from 2001 to 2008.

Authors:  Mohammad Ebrahimipour; Christine M Budke; Mohsen Najjari; Kambiz Yaghoobi
Journal:  J Parasit Dis       Date:  2017-03-30

2.  Lone, Mobile Left Atrial Hydatid Cyst.

Authors:  Bahadir Sarli; Mehmet Ugurlu; Ahmet Oguz Baktir; Ali Ihsan Tekin; Ahmet Tok; Bayram Yagmur
Journal:  Tex Heart Inst J       Date:  2016-06-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.